Select publications

Ghielmini M et al. Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule. Blood 2004;103(12):4416-23. Abstract

Hainsworth JD et al. Rituximab as first-line and maintenance therapy for indolent non-Hodgkin’s Lymphoma (NHL): Long-term follow-up of a Minnie Pearl Cancer Research Network phase II trial. Blood 2003;102(11);Abstract 1496.

Hainsworth JD et al. Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin’s lymphoma. J Clin Oncol 2002;20(20):4261-7. Abstract

Hainsworth JD et al. Scheduled rituximab maintenance therapy versus rituximab retreatment at progression in patients with indolent non-Hodgkin s lymphoma (NHL) responding to singleagent rituximab: A randomized trial of the Minnie Pearl Cancer Research Network. Blood 2003;102(11);Abstract 231.

Hiddemann W et al. Combined immuno-chemotherapy (R-CHOP) significantly improves time to treatment failure in first line therapy of follicular lymphoma: Results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). Blood 2003;102(11);Abstract 352.

Keating M, O’Brien S. High-dose rituximab therapy in chronic lymphocytic leukemia. Semin Oncol 2000;27(6 Suppl 12):86-90. Abstract

Maloney DG et al. IDEC-C2B8: Results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin’s lymphoma. J Clin Oncol 1997;15:3266-74. Abstract

Maloney DG et al. Phase I clinical trial using escalating single-dose infusion of chimeric anti- CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood 1994;84:2457-66. Abstract

Maris MB et al. Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma. Blood 2004; Aug 10: Epub ahead of print. Abstract

O’Brien SM et al. Rituximab dose-escalation trial in chronic lymphocytic leukemia. J Clin Oncol 2001;19(8):2165-70. Abstract

Solal-Celigny P et al. Follicular lymphoma international prognostic index. Blood 2004;104(5):1258- 65. Abstract